Exane Derivatives Cooper Companies, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Cooper Companies, Inc. stock. As of the latest transaction made, Exane Derivatives holds 9 shares of COO stock, worth $810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 63
85.71%
Holding current value
$810
Previous $26,000
92.31%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding COO
# of Institutions
47Shares Held
1.22MCall Options Held
0Put Options Held
200-
Intermede Investment Partners LTD728KShares$65.5 Million1.79% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8143KShares$12.8 Million0.07% of portfolio
-
Eaton Vance Management Boston, MA86.1KShares$7.75 Million0.03% of portfolio
-
Brant Point Investment Management LLC New York, NY75KShares$6.75 Million1.79% of portfolio
-
Crystal Rock Capital Management52.6KShares$4.74 Million3.11% of portfolio
About COOPER COMPANIES, INC.
- Ticker COO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 49,346,000
- Market Cap $4.44B
- Description
- The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...